Clinical and pharmacy-economical reasonability of the choice of fixed combination of fluticasone/salmeterol in the curing of bronchial asthma in the country with limited financing of the public health

D. Ruzanov, E. Davidovskaya, T. Baranovskaya (Gomel, Minsk, Belarus)

Source: Annual Congress 2011 - Understanding the burden of chronic respiratory diseases: what decision makers need to know
Disease area: Airway diseases

Congress or journal article abstractE-posterSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Ruzanov, E. Davidovskaya, T. Baranovskaya (Gomel, Minsk, Belarus). Clinical and pharmacy-economical reasonability of the choice of fixed combination of fluticasone/salmeterol in the curing of bronchial asthma in the country with limited financing of the public health. Eur Respir J 2011; 38: Suppl. 55, 1683

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Budesonide/formoterol in a single inhaler improves health status in patients with COPD without increasing healthcare costs
Source: Eur Respir J 2003; 22: Suppl. 45, 50s
Year: 2003

Improving asthma care with use of asthma action plan and inhaler technique check in a children‘s hospital
Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma
Year: 2010

Does systematic assessment improve healthcare outcomes and healthcare utilisation in patients with severe asthma?
Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments?
Year: 2011


Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018


Is the Spanish primary health care reform improving clinical management of asthma?
Source: Eur Respir J 2001; 18: Suppl. 33, 400s
Year: 2001

Clinical impact of a program to educate community pharmacists in providing proper inhalation technique for asthma patients
Source: Annual Congress 2011 - Medical education
Year: 2011


The paradox of primary care and respiratory health: evidence of benefit for people and populations with asthma and COPD
Source: Annual Congress 2011 - Primary Care Day I: Effective disease- and self-management in primary care
Year: 2011


Difference in healthcare resource use among children with asthma who did and did not have allergic rhinitis diagnosis in a UK primary care database
Source: Eur Respir J 2002; 20: Suppl. 38, 332s
Year: 2002

Cost of asthma in patients treated with national asthma guideline in Turkey
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003

COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

Suboptimal asthma control among over-the-counter reliever purchasers in the community pharmacy.
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019

The clinical and economic impact of the combined interventions of telehealth, specialist respiratory nursing care and health coaching interventions for COPD admissions within an urban setting
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Does having specialist asthma nurses improve adherence to national asthma guidelines? A comparison between two UK district general hospitals
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


Cost of health care associated with workplace exacerbation of asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 157s
Year: 2007

Is asthma treatment compliance improved over the last ten years? The results of the European community respiratory health survey (ECRHS)-II
Source: Annual Congress 2004 - Asthma and allergy overtime: risks and management
Year: 2004


Does an mHealth system reduce health service use for asthma?
Source: ERJ Open Res, 6 (3) 00340-2019; 10.1183/23120541.00340-2019
Year: 2020



Improving accessibility to spirometry in primary health care
Source: Annual Congress 2010 - Diagnostic and therapeutic strategies in primary care
Year: 2010

Effects of an asthma mHealth system on health services use: A pragmatic trial
Source: International Congress 2019 – M-health/e-health I
Year: 2019